There is a conspiracy that often is met by scoffs and rolled eyes when discussed. A conspiracy that is so egregious that many regular people still don’t believe a human, or even a company is capable of. I am here to tell you why that conspiracy is much more real and much more destructive to your personal health, and the wellbeing of society as a whole, than you may think.
That conspiracy is that big pharma, the companies responsible for medicine and cures to deadly diseases, truly seeks to keep you sick, rather than curing ailments, so that big pharma and their investors can keep making billions of dollars off you.
While this may seem counterintuitive to an industry that seeks to treat and cure illness and diseases, the evidence is right in front of us. Let’s talk about a cure for Hepatitis C for example. What you may not know is that there was a drug created in 2014, which has a greater than ninety percent cure rate for Hepatitis C. Strange that this wouldn’t have been major headline news around the globe? To understand why it isn’t more common knowledge, we must talk about the pharmaceutical company who marketed this cure and the bank that financed the pharmaceutical company.
Back in 2014, a pharmaceutical company by the name of Gilead got FDA approval for the drug Harvoni, they then placed it on the market in the UK, Canada, and the United States. This drug had a greater than ninety percent cure rate for Hepatitis C. This was amazing news! Doctors and patients around the world were happy to hear that finally we had a cure for a chronic medical condition, that previously we had no cure for. Prior to Harvoni, the best we could do was treat the symptoms. You would think that this would be big news, that it would be shouted from the roof tops, but that did not happen.
The reason that this miracle cure is not more widely known about is mainly due to Goldman Sachs. We know this because they said the quite part out loud in a statement to Gilead. Goldman Sachs said the potential to deliver a one-shot cure is one of the most attractive aspects of gene therapy genetically engineered cell therapy and gene editing. However, such treatments offer a very different outlook in regards to recurring revenue versus chronic therapies. While this proposition carries tremendous values for patient and society it could represent a challenge for cash flow.
Now you would think that all the major news corporations and leading medical magazines would come up with monthly updates on this story, forcing golden Sachs to say they were sorry for saying that. You would assume that Golden Sachs would backtrack and say that of course they wanted big pharma to come up with cures if possible and that they would fund research into finding cures and not just funding the management of chronic medical diseases.
Instead, aside from a few stories from smaller media outlets, there were no articles, no updates, and eventually the story just went away. Goldman Sachs had made it very clear, that if a pharmaceutical company invested in cures, it was a bad financial investment, they were wasting the institutions money on a product that would produce low returns, and they were not going to be interested in future business like that.
You would think that the media would not let a story with such ramifications for society as a whole die. Well, that too comes down to money. Big pharma funds most of the mainstream news media organizations that people trust. They have billions of dollars in advertising budgets that they will hold over CNN, Fox news, MSNBC and anyone else’s head and say, if you give us bad press, we will pull our ads.
With big banks not funding research into cures, big pharma focuses their efforts on management instead of any research that might lead to cures of other chronic medical conditions. They would much rather sell you a pill a day to manage your condition, instead of selling you a twelve-week regiment that cures your condition. Because, as Goldman Sachs so blatantly put it, they would not make that recurring revenue on and thus it would be a bad investment.
Selling the management of a condition is a cash cow, going forward you most likely won’t see anymore cures for chronic diseases, you will only see new and updated treatments and therapies and management for chronic medical conditions. Unfortunately, unless you have billions of dollars to give for research, your opinion does not matter.
Tell us what you think; comment below and share this post with your friends!